Stockscreener 앱 받기
34.64
0.06%
-0.02
시장 영업 전:
34.06
-0.58
-1.67%
전일 마감가:
$34.66
열려 있는:
$33.79
하루 거래량:
447.92K
Relative Volume:
0.44
시가총액:
$1.69B
수익:
$96.21M
순이익/손실:
$-12.13M
주가수익비율:
-110.67
EPS:
-0.313
순현금흐름:
$10.64M
1주 성능:
+7.74%
1개월 성능:
+22.92%
6개월 성능:
+52.94%
1년 성능:
+52.73%
1일 변동 폭
$33.75
$34.92
1주일 범위
$31.46
$34.92
52주 변동 폭
$17.86
$34.92
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
34.64 | 1.46B | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
393.38 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.63 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.63 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.05 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.81 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2024-09-30 | 개시 | H.C. Wainwright | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-11 | 개시 | Craig Hallum | Buy |
| 2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-19 | 개시 | B. Riley Securities | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-18 | 개시 | Cowen | Outperform |
| 2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-08 | 재확인 | Maxim Group | Buy |
| 2020-02-24 | 개시 | Lake Street | Buy |
| 2020-02-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 재개 | B. Riley FBR | Buy |
| 2020-01-08 | 개시 | Stephens | Overweight |
| 2019-11-21 | 개시 | Oppenheimer | Outperform |
| 2019-07-22 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 재확인 | Maxim Group | Buy |
| 2017-09-19 | 재확인 | Maxim Group | Buy |
| 2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
| 2017-03-10 | 재확인 | Maxim Group | Buy |
| 2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
Biolife Solutions stock hits 52-week high at 32.24 USD - Investing.com
Biolife Solutions stock hits 52-week high at 32.24 USD By Investing.com - Investing.com UK
BLFS|BioLife Solutions Inc|Price:29.950|Chg%:-0.030 - TradingKey
BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioLife Solutions Inc (BLFS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BLFS|BioLife Solutions Inc|Price:29.980|Chg%:-0.790 - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioLife Solutions, Inc. Revenue Breakdown – GETTEX:BJX1 - TradingView
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc.BLFS - Business Wire
Repligen Corporation to Acquire BioLife Solutions for $1.5 Billion, Boosting Cell Therapy Market Presence - Kalkine Media
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal - Stock Titan
BioLife Solutions Inc (BLFS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo Finance
BIOLIFE SOLUTIONS INC : JEFFERIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $31 FROM $30 - Bitget
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition - Sahm
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - TradingView
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30 - Moomoo
BIOLIFE SOLUTIONS INC : TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $31 FROM $33 - Bitget
Bothell firm fetches $1.5 billion in acquisition by Massachusetts company - The Business Journals
Repligen Corporation (RGEN) BioLife Solutions, Inc.,M&A CallSlideshow (NASDAQ:RGEN) 2026-07-23 - Seeking Alpha
Repligen to Acquire BioLife Solutions for $1.5 Billion, Expanding Leadership in Cell Therapy Market - Minichart
BioLife Solutions Inc (BLFS) Stock Up 6.8% but GF Value Says Ove - GuruFocus
BioLife Solutions Cut to Hold From Buy by Lake Street - Moomoo
BioLife Solutions to Be Acquired by Repligen Corporation - TipRanks
Repligen to Acquire Bothell's BioLife Solutions in $1.5B Deal - 425business.com
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per Share - TradingView
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-stock deal - Stock Titan
Repligen to Acquire BioLife Solutions for $11.25 per Share Plus Stock, Enhancing Cell Processing Capabilities - Kalkine Media
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach - Yahoo Finance
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) - PR Newswire
Repligen targets cell therapy expansion as Waltham firm inks $1.5 billion acquisition - The Business Journals
BioLife Solutions downgraded to Hold amid $1.5B Repligen acquisition and shareholder fairness probe - Pluang
Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal, Expanding Into Cell Therapy - finance.biggo.com
Repligen Corporation entered into an agreement and plan of merger to acquire BioLife Solutions, Inc. for approximately $1.6 billion. - marketscreener.com
Ademi LLP Investigates Whether BioLife Solutions, Inc. Is Obtaining a Fair Price for Public Shareholders - 富途牛牛
Repligen buys BioLife Solutions for $1.5 billion - grafa.com
Repligen to buy BioLife Solutions for USD 1.5 billion in cash-and-stock deal - Bitget
BioLife Solutions Inc - Reuters
Repligen Announces Acquisition of BioLife Solutions in $11.25 Per Share Cash and Stock Deal - Kalkine Media
Repligen to Acquire BioLife Solutions in Cash and Stock Merger Valued at $11.25 Per Share - Kalkine Media
What's Going on With Repligen Stock Wednesday?Repligen (NASDAQ:RGEN), BioLife Solutions (NASDAQ:BLFS) - Benzinga
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders - New Castle News
Repligen Corp To Acquire BioLife Solutions Transcript - GuruFocus
Repligen to acquire BioLife Solutions for $1.5 billion By Investing.com - Investing.com Nigeria
Repligen to buy cell therapy maker BioLife in $1.5 billion deal - Reuters
Repligen to acquire BioLife Solutions for $1.5 billion - Investing.com
Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal - marketscreener.com
BioLife SolutionsDeal Expected to Be Accre - Moomoo
Press Release: Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities With Market Leading Biopreservation Media - Moomoo
Goodwin Advises Repligen In Acquisition Of BioLife Solutions For Approximately $1.5 Billion - Mondaq
Form 4 BioLife Solutions Inc For: 21 July By Investing.com - Investing.com Nigeria
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
바이오라이프 솔루션즈 주식 (BLFS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | 10% Owner |
May 19 '26 |
Sale |
22.65 |
300,000 |
6,795,000 |
5,657,165 |
| Casdin Partners Master Fund, L | 10% Owner |
May 20 '26 |
Sale |
23.70 |
250,000 |
5,925,000 |
5,407,165 |
1.37%
0.55%
자본화:
|
볼륨(24시간):